APP and familial Alzheimer disease: Usually, transgenic mice carrying multiple familial Alzheimer’s disease (FAD) mutations, such as APPswe/PSEN1ΔE9 (APP/PS1), 5xFAD and in triple-transgenic (3xTg), exhibit more significant Aβ deposition and progression of behavioral deficits compared to single APP transgenic mice [161–163].